Insight

Ilya Tsimafeyeu: Intrapleural nivolumab in cancer patients with pleural effusion

Photo of Ilya Tsimafeyeu

Jul 23, 2024, 10:09

Ilya Tsimafeyeu: Intrapleural nivolumab in cancer patients with pleural effusion

Ilya Tsimafeyeu, Director at the Bureau of Cancer Research, shared on Facebook about a recent paper titled “Intrapleural nivolumab in cancer patients with pleural effusion” published in the Journal of Cancer Research and Therapeutics.

Authors: Tsimafeyeu Ilya, Goutnik Vadim, Shrainer Igor, Kosyrev Vladislav, Bondarenko Anastasia, Utyashev Igor

Ilya Tsimafeyeu

“We tried to use intrapleural nivolumab in cancer patients with pleural effusion, but unfortunately, it did not yield the desired results.

How do you treat recurrent, resistant pleural effusions in your practice?”

Source: Ilya Tsimafeyeu/Facebook

Bondarenko Anastasia cancer Goutnik Vadim Ilya Tsimafeyeu Journal of Cancer Research and Therapeutics Kosyrev Vladislav nivolumab OncoDaily Oncology pleural effusion Shrainer Igor Tsimafeyeu Ilya Utyashev Igor

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Top 10 Immunotherapy Fellowships and Grants to Watch in 2025

July Is Sarcoma Awareness Month: What You Need to Know

Pat Soon-Shiong: SARS-CoV-2 Infection Can Awaken Sleeping Cancer Cells

Cary Adams' Keynote Message at Parliament House in Canberra - UICC